Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
91-105 of 1760 results
hVIVO invests in PrEP Biopharm
By PBR Staff Writer
hVIVO has made an investment in the UK-based start-up, PrEP Biopharm, to further develop new prophylactic treatment for respiratory infections.
Automation > IT & Software > News
Scientists investigate biodegradable nanomedicine to improve ovarian cancer treatments
Scientists are investigating a biodegradable nanomedicine that can selectively destroy ovarian cancer cells left behind after surgery.
Automation > IT & Software > News
CEVEC, BioLamina partner for commercial production of recombinant laminins for ex vivo cell therapies
CEVEC Pharmaceuticals and BioLamina have formed a collaboration for the commercial production of research grade and clinical grade laminins for ex vivo cell culture applications.
Automation > IT & Software > News
Report says global endoscopy market value will increase to almost $9.7bn by 2021
The global endoscopy market will rise in value from $5.7 billion in 2014 to just under $9.7 billion by 2021, representing a Compound Annual Growth Rate (CAGR) of 6.9%, according to research and consulting firm GlobalData.
Automation > IT & Software > News
COMS Interactive inks deal to incorporate INTERACT program into Daylight IQ
Clinical Outcomes Management Systems (COMS Interactive) has executed a license agreement with Florida Atlantic University (FAU) to automate the process of populating the INTERACT 4.0 document toolset with the rich clinical data collected through the Daylight IQ software and clinical guidance.
Automation > IT & Software > News
Genmab announces $3m milestone payment in DuoBody platform collaboration with Janssen
Genmab has achieved a milestone in its DuoBody technology platform collaboration with Janssen Biotech, triggering a $3m milestone payment.
Automation > IT & Software > News
Capsugel introduces enTRinsic drug delivery technology platform
By PBR Staff Writer
Capsugel has launched its enTRinsic drug delivery technology platform, which offers enteric protection without the requirement of functional coatings.
Automation > IT & Software > News
Horizon Pharma gets USPTO patent for PENNSAID (diclofenac sodium topical solution) 2%
Horizon Pharma has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for US patent application number 14/705,649 (U.S. publication number 2015-0231264), entitled "Diclofenac Topical Formulation" that covers its US approved product PENNSAID (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%).
Automation > IT & Software > News
Humana unveils real-time prescription drug benefit service
Humana has announced a real-time prescription drug benefit service that gives doctors information about their Humana patients’ drug coverage, pricing and network pharmacy options all while the patient is in the exam room.
Automation > IT & Software > News
Quintiles, IMS Health partner to advance use of real-world evidence in late-stage clinical research
Quintiles and IMS Health have formed a global strategic alliance that will advance the way biopharmaceutical companies generate real-world evidence (RWE) and apply critical insights to drive late-stage clinical research.
Automation > IT & Software > News
Rio Grande buys Cervel Neurotech’s Multi-Coil TMS technology to treat drug resistant depression
Rio Grande Neurosciences has acquired Cervel Neurotech’s multi-coil Transcranial Magnetic Stimulation (rTMS) technology, including all related patent applications, issued patents, trademarks and equipment.
Automation > IT & Software > News
Enteris BioPharma's formulation technology enables oral delivery of Tarsa Therapeutics' TBRIA
Enteris BioPharma has congratulated Tarsa Therapeutics on the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for TBRIA (calcitonin-salmon [rDNA origin] delayed release tablets) in July 2015, which has now been accepted for review by the FDA with a user fee goal date of May 30, 2016.
Automation > IT & Software > News
Scientists design new delivery system for protease inhibitors
Scientists at the University of Nebraska Medical Center designed a new delivery system for protease inhibitors that, when coupled with a drug developed at the University of Rochester School of Medicine and Dentistry, rid immune cells of HIV and kept the virus in check for long periods.
Automation > IT & Software > News
Emisphere, Novo Nordisk to develop four oral formulations using Eligen technology
By PBR Staff Writer
Emisphere Technologies and Novo Nordisk have entered into an agreement to develop and commercialize oral formulations of four molecules for metabolic disorders.
Automation > IT & Software > News
Sphaera Pharma receives notice of allowance from USPTO for drug modification platform technology
Sphaera Pharma has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for its Patent application titled ‘Substituted methylformyl reagents and method of using same to modify physicochemical and/ or pharmacokinetic properties of compounds’, for its platform technology.
Automation > IT & Software > News
91-105 of 1760 results